AKTX Logo

Akari Therapeutics, Plc (AKTX) 

NASDAQ
Market Cap
$25.54M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
525 of 963
Rank in Industry
283 of 552

Largest Insider Buys in Sector

AKTX Stock Price History Chart

AKTX Stock Performance

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

Insider Activity of Akari Therapeutics, Plc

Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of Akari Therapeutics, Plc stock.

On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,055,600 shares for transaction amount of $200,036 was made by Cohen Mark S (director) on 2015‑09‑18.

List of Insider Buy and Sell Transactions, Akari Therapeutics, Plc

2015-09-18Purchasedirector
1.06M
0.0711%
$0.19$200,036-56.76%
2014-04-15Purchase10 percent owner
17,100
0.3007%
$5.00$85,500+9.59%
2014-04-14Purchase10 percent owner
3,000
0.0539%
$5.21$15,630+7.49%
2014-04-11Purchase10 percent owner
100
0.0017%
$5.15$515+3.70%
2014-04-10Purchase10 percent owner
1,400
0.0252%
$5.25$7,350+6.67%
2014-04-09Purchase10 percent owner
1,075
0.0194%
$5.51$5,923+1.82%
2014-04-08Purchase10 percent owner
35,500
0.6218%
$5.36$190,280+1.82%
2014-04-07Purchase10 percent owner
20,654
0.3716%
$5.71$117,840-1.75%
2014-04-04Purchase10 percent owner
12,250
0.216%
$6.07$74,400-9.53%
2014-04-02Purchase10 percent owner
2,500
0.0441%
$6.15$15,375-10.69%
2014-04-01Purchase10 percent owner
15,371
0.2742%
$6.10$93,806-8.94%
2014-03-31Purchase10 percent owner
7,936
0.1396%
$6.35$50,394-13.63%
2014-03-27Purchase10 percent owner
1,700
0.0344%
$6.61$11,237-14.92%
2014-03-26Purchase10 percent owner
14,200
0.2876%
$6.66$94,619-15.34%
2014-03-25Purchase10 percent owner
303
0.0061%
$6.90$2,091-18.99%
2014-03-24Purchase10 percent owner
2,400
0.0465%
$6.71$16,104-19.43%
2014-03-21Purchase10 percent owner
4,900
0.1002%
$6.83$33,467-16.36%
2014-03-20Purchase10 percent owner
3,800
0.0768%
$6.90$26,220-18.12%
2014-03-17Purchase10 percent owner
2,400
0.0479%
$6.65$15,960-16.17%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.